- Joined
- Apr 4, 2006
- Messages
- 19,538
N&PD Moderators: Skorpio
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an alternative browser.
A supposed new painkiller that blocks the PN1 channell
Didnt they try a similar thing with some kind of drug derived from snail venom that was supposed to be 1000 times stronger then morphine or something? I think that turned out to be a flop in clinical trials or it might have even have made it past clinical trials and flopped.
I suffer from neuropathic pain and im just very wary of anything that is supposed to be a wonder drug for it. I remember gabapentin being a wonder drug for it then lyrica was the wonder drug. Although both of them help me alot neither controls the pain anywhere near enough on their own and i would be in agony if it was not for morphine.
Not that i intend to go off morphine or opiates in general but i was just wondering about this supposed wonder drug and how well it would actually work. I have no clue about the PN1 channel so i couldnt decifer this shit at all.
23536
Bluelight Crew
Didnt they try a similar thing with some kind of drug derived from snail venom that was supposed to be 1000 times stronger then morphine or something? I think that turned out to be a flop in clinical trials or it might have even have made it past clinical trials and flopped.
ziconotide is available, but you need to be fitted with a pump that delivers it into your spine
there was some talk about putting it into liposomes
whitemilk661
Bluelighter
get into pfizer stock while you can..
get into pfizer stock while you can..
pfizer are pfinished
Hammilton
Bluelighter
Probably not. Their stock is trading near just of a 52 week high. Still, taking a long term approach, it's really off since even 2007, and no where near it's ten-year high. None of these companies look that great right now, though, but I doubt it's going anywhere anytime soon.
I'd put money on Pfizer before I'd put money on Merck. Pfizer is still at about 19.17 bucks a share, not exactly going-away prices, and Merck is at 32.90, but it's been sliding and I don't think anything is going to stop it anytime soon.